These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 24513012

  • 1. Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.
    Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, van der Klis F, Berbers G.
    Vaccine; 2014 Apr 01; 32(16):1890-5. PubMed ID: 24513012
    [Abstract] [Full Text] [Related]

  • 2. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 3. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
    Cohen D, Muhsen Kh, Aboudy Y, Harari H, Mendelson E, Green MS.
    Vaccine; 2006 Jul 07; 24(27-28):5604-8. PubMed ID: 16716460
    [Abstract] [Full Text] [Related]

  • 4. Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey.
    Yalcin A, Caliskan D, Isik A.
    East Mediterr Health J; 2008 Jul 07; 14(5):1036-43. PubMed ID: 19161075
    [Abstract] [Full Text] [Related]

  • 5. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.
    Hahné S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, Tipples G, Ruijs H, Mazzulli T, Timen A, van Loon A, de Melker H.
    Pediatr Infect Dis J; 2009 Sep 07; 28(9):795-800. PubMed ID: 19710586
    [Abstract] [Full Text] [Related]

  • 6. Success and failure of a rubella immunization programme.
    Swartz TA, Porath EB, Hornstein L.
    Dev Biol Stand; 1979 Sep 07; 43():355-60. PubMed ID: 520682
    [Abstract] [Full Text] [Related]

  • 7. Rubella Seroprevalence among the General Population in Dongguan, China.
    Lin W, Wang D, Xiong Y, Tang H, Liao Z, Ni J.
    Jpn J Infect Dis; 2015 Sep 07; 68(3):192-5. PubMed ID: 25672349
    [Abstract] [Full Text] [Related]

  • 8. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
    van Lier A, Smits G, Mollema L, Waaijenborg S, Berbers G, van der Klis F, Boot H, Wallinga J, de Melker H.
    Vaccine; 2013 Oct 17; 31(44):5127-33. PubMed ID: 23973248
    [Abstract] [Full Text] [Related]

  • 9. Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.
    Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L.
    PLoS One; 2016 Oct 17; 11(2):e0148605. PubMed ID: 26863307
    [Abstract] [Full Text] [Related]

  • 10. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM.
    Ann Rheum Dis; 2012 Jun 17; 71(6):948-54. PubMed ID: 22172491
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ, Huang LM, Chen HH, Hwang KC, Chen CJ.
    J Med Virol; 2007 Jan 17; 79(1):97-103. PubMed ID: 17133552
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program.
    Wang IJ, Hwang KC, Tsai YH, Wu YN, Chao SJ, Chen TE, Huang LM.
    Acta Paediatr Taiwan; 2006 Jan 17; 47(1):14-7. PubMed ID: 17016964
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
    Levine H, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Zarka S, Balicer RD.
    Vaccine; 2012 Nov 26; 30(50):7260-4. PubMed ID: 23063839
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.